Colbeck Capital Management provided $125 million in financing to Woodward Pharma Services, LLC ("Woodward") and its affiliate Future Pak Ltd. ("Future Pak").
Woodward and Future Pak, headquartered in Wixom, MI, are headed by industry veterans, David Risk and Ray Canole. Woodward is a specialty pharmaceutical company focused on acquiring, licensing, and commercializing branded and generic prescription drugs for the U.S. market. Future Pak is a pharmaceutical and over-the-counter contract manufacturing and packaging organization.
The funding from Colbeck Capital is being used to accelerate company growth by expanding the platform and acquiring branded pharmaceutical products from long-standing relationships.
"We couldn't be more excited to partner with David, Ray, and the entire Woodard team as they look to grow the business into a premier pharmaceutical platform," said Jason Colodne, Managing Partner and co-founder of Colbeck Capital.
"Upon meeting the Woodward team, I knew they could be a dependable partner as demonstrated by their high standards in quality and customer service. These are attributes which we look for in businesses we invest in," added Jason Beckman, Managing Director and founding partner of Colbeck Capital.
Bourne Partners served as exclusive advisor to Woodward in conjunction with the financing and the transactions.